Chemical Compound

Erythromycin A enol ether

CAS Registry Number 33396-29-1
Erythromycin A enol ether chemical structure
Primary Record

Erythromycin A enol ether

In stock
1,467 g
Purity
99.8 %
CAS
33396-29-1

Compound Identifiers & Properties

CAS
33396-29-1
PubChem CID
83954
SMILES
CC[C@@H]1[C@@]([C@@H]([C@H](C2=C(C[C@@](O2)([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)OC)C)O[C@H]4[C@@H]([C@H](C[C@H](O4)C)N(C)C)O)C)C)C)O)(C)O
Canonical SMILES
CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@@]2(C)CC(C)=C(O2)[C@H](C)[C@@H](O)[C@]1(C)O

Names & Synonyms

  • Erythromycin A enol ether
  • Erythromycin enol ether
  • EM-A enolether
  • 33396-29-1
  • Erythromycin EP Impurity E
  • RefChem:137779
  • EM523L
  • Erythromycin-A enol ether
  • ME-4
  • EM-201
  • 8,9-anhydroerythromycin A
  • D03FQP
  • UNII-32B40I7V7B
  • AC1L36IA
  • ME 4
  • 32B40I7V7B
  • 8,9-anhydroerythromycin A 6,9-hemiketal
  • BRL 46357ER
  • BRL-46357ER
  • Erythromycin A 6,9-enolether
  • EM 523
  • JFVYXJKGJMUGRG-KJPZRSJGSA-N
  • C37H65NO12
  • CHEMBL300004
  • GTPL1448
  • orb1306293
  • SCHEMBL12101978
  • BDBM85846
  • CHEBI:184048
  • EM 201
  • EM-523
  • DTXSID801371991
  • EM201
  • EM523
  • ME523
  • CID83954
  • MSK14276
  • ZINC94303286
  • AKOS040744877
  • C37-H65-N-O12
  • MSK14276-100M
  • FE22798
  • DA-52997
  • CAS_33396-29-1
  • Erythromycin, 8,9-didehydro-9-deoxo-6-deoxy-6,9-epoxy-
  • HY-122207
  • J247.117E
  • LS-174415
  • CS-0082649
  • ERYTHROMYCIN IMPURITY E [EP IMPURITY]
  • G87572
  • (2R,3R,4S,5R,8R,9S,10S,11R,12R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-5-ethyl-3,4-dihydroxy-9-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-6,15-dioxabicyclo[10.2.1]pentadec-1(14)-en-7-one
  • 8,9-Didehydro-9-deoxo-6-deoxy-6,9-epoxyerythromycin
  • ERYTHROMYCIN EP IMPURITY E (REFERENCE GRADE)
  • (6R)-6-Deoxy-9-deoxo-6,9-epoxy-8,9-didehydroerythromycin
  • 6,9-Epoxy-8,9-didehydro-9-deoxo-6-deoxyerythromycin
  • 6-Deoxy-9-deoxo-8,9-didehydro-6,9-epoxyerythromycin
  • 9-Deoxo-6-deoxy-6,9-epoxy-8,9-didehydroerythromycin
  • ERYTHROMYCIN ESTOLATE IMPURITY E [EP IMPURITY]
  • ERYTHROMYCIN STEARATE IMPURITY E [EP IMPURITY]
  • N-Ethyl-N-demethyl-8,9-anhydroerythromycin A 6,9-hemiketal
  • Q27083849
  • De-(N-methyl)-N-ethyl-8,9-anhydroerythromycin A 6,9-hemiacetal
  • (6R)-6,9-Epoxy-6-deoxy-9-deoxo-8,9-didehydroerythromycin
  • 6beta,9-Epoxy-8,9-didehydro-9-deoxo-6-deoxyerythromycin
  • Erythromycin A enol ether Solution in Methanol, 100ug/mL
  • ERYTHROMYCIN ETHYLSUCCINATE IMPURITY E [EP IMPURITY]
  • ERYTHROMYCIN LACTOBIONATE IMPURITY E [EP IMPURITY]
  • (2R,3R,4S,5R,8R,9S,10S,11R,12S)-5-ethyl-11-[(2S,3R,4S,6R)-4-[ethyl(methyl)amino]-3-hydroxy-6-methyloxan-2-yl]oxy-3,4-dihydroxy-9-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-6,15-dioxabicyclo[10.2.1]pentadec-1(14)-en-7-one
  • ME4
  • (1R,2R,3S,4S,5R,8R,9S,10R,11R)-2-[(2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6-methyloxan-2-yl]oxy-8-ethyl-9,10-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-1,3,5,9,11,13-hexamethyl-7,15-dioxabicyclo[10.2.1]pentadec-12-en-6-one
  • (2R,3R,4S,5R,8R,9S,10S,11R,12R)-11-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-5-ethyl-3,4-dihydroxy-9-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-2,4,8,10,12,14-hexamethyl-6,15-dioxabicyclo[10.2.1]pentadec-1(14)-en-7-one
  • (2R,3R,4S,5R,8R,9S,10S,11R,12R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-5-ethyl-3,4-dihydroxy-9-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-2,4,8,10,12,14-hexamethyl-6,15-dioxabicyclo[10.2.1]pentadec-1(14)-en-7-one
  • (2R,3R,4S,5R,8R,9S,10S,11R,12R)-11-{[(2S,3R,4S,6R)-4-(DIMETHYLAMINO)-3-HYDROXY-6-METHYLOXAN-2-YL]OXY}-5-ETHYL-3,4-DIHYDROXY-9-{[(2R,4R,5S,6S)-5-HYDROXY-4-METHOXY-4,6-DIMETHYLOXAN-2-YL]OXY}-2,4,8,10,12,14-HEXAMETHYL-6,15-DIOXABICYCLO[10.2.1]PENTADEC-1(14)-EN-7-ONE
  • (2R,3R,4S,5R,8R,9S,10S,11R,12R)-9-((2,6-DIDEOXY-3-C-METHYL-3-O-METHYL-.ALPHA.-L-RIBO-HEXOPYRANOSYL)OXY)-5-ETHYL-3,4-DIHYDROXY-2,4,8,10,12,14-HEXAMETHYL-11-((3,4,6-TRIDEOXY-3-(DIMETHYLAMINO)-.BETA.-D-XYLO-HEXOPYRANOSYL)OXY)-6,15-DIOXABICYCLO(10.2.1)PENTADEC-1(14)-EN-7-ONE
  • 11-(4-Dimethylamino-3-hydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-5-ethyl-3,4-dihydroxy-9-(5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydr o-pyran-2-yloxy)-2,4,8,10,12,14-hexamethyl-6,15-dioxa-bicyclo[10.2.1]pentadec-1(14)-en-7-one
  • Erythromycin Imp. E (EP); Erythromycin A Enol Ether; Erythromycin Estolate Impurity E; Erythromycin Ethylsuccinate Impurity E; Erythromycin Impurity E; Erythromycin Lactobionate Impurity E; Erythromycin Stearate Impurity E
  • N/A